Treatment of Adipose Tissue and Skin Laxity at the Buttocks by PDLLA, US and RF
NCT ID: NCT07010796
Last Updated: 2025-06-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10 participants
OBSERVATIONAL
2025-01-15
2025-05-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety and Efficacy of the BTL-703 Treatment for the Non-invasive Lipolysis
NCT03545360
Percutaneous Electroneurostimulation of Dermatome T6 for Appetite Reduction and Weight Loss in Morbidly Obese Patients
NCT01792947
Non-invasive Lipolysis on Human Thighs and Saddlebags
NCT04221646
Safety and Efficacy of the BTL-785F Device for Non-invasive Reduction of Submental Fat
NCT05831332
BTL-785F Device for Non-invasive Lipolysis and Circumference Reduction of the Abdomen
NCT04621019
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Alma Prime X
Alma Prime x is a platform that provides applicators for radiofrequency and ultrasound.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients eligible to be treated with radiofrequency and ultrasound
* all genders
Exclusion Criteria
* pregnancy
* immune diseases
* active virus infections
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pablo Naranjo García, MD
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pablo Naranjo García, MD
Principle Investigator Pablo Naranjo Garcia, MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Elite Laser Clinic Organization
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PDLLA-UD/RF-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.